In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
The team discusses the practical advantages of oral glutathione supplementation compared to intravenous administration
PowerLab software (8SP, AD Instruments, Colorado Spring, CO) was used to record mean arterial pressure (MAP) and heart rate (HR), simultaneously
200 WeldonC
Importance of Neurological Symptoms Neurological symptoms are a critical and sometimes early feature of B12 deficiency in PA
Some report an increase in energy, confidence, and even sexual desire as they lose weight